CONMED Corp.'s CONMED Linvatec arthroscopy unit announced the release of new sizes of its Matryx(TM) Biocomposite Interference Screw. These new screws represent the latest advance in biocomposite material technology that allows CONMED Linvatec to produce the smallest Biocomposite Interference screw available on the market for primary fixation of ACL and PCL grafts. The company will debut the product at the Fall Arthroscopy Association of North America (AANA) meeting in Palm Springs, CA, which takes place November 19-21, 2009. The placement of the screw in the boney tunnel with the ligament results in compression of the ligament against the boney surface of the tunnel. Such compression allows the tissue to be held in place and provides for the integration of the replacement ligament with the bone via natural healing pathways. The Matryx biocomposite screw encourages bone formation due to the presence of the bone pre-cursor Beta TriCalcium Phosphate, resulting in strong bone reconstruction and integration of the replacement ligament. Matryx screws are absorbed by the body over time and foster new bone formation around the repaired ligament. These new smaller screw sizes (5.0 - 6.5mm diameters) are manufactured with a novel processing technology that produces the smallest Biocomposite interference screws currently on the market.

CONMED Corp.'s CONMED Linvatec arthroscopy unit announced the release of the Bullseye(TM) Anatomic Cruciate Reconstruction System, a novel guide system for anatomic cruciate ligament (ACL and PCL) reconstructions of the knee. The Company will debut the product at the Fall Arthroscopy Association of North America (AANA) meeting in Palm Springs, CA, which takes place November 19-21, 2009. The Bullseye System will provide surgeons the ability to more precisely perform anatomic single bundle and double bundle cruciate reconstructions with a flexible and intuitive guide system. The Bullseye System will be supported with new sizes of advanced Matryx(TM) biocomposite interference screws. The Bullseye System consists of anatomic drill guides that visually depict the placement and size of the tunnel to be created and filled with the new ligament. The guides aid placement in the remnants of the original ligament and ensure that the ligament will be correctly positioned without damaging, or interfering with, nearby structures such as knee cartilage surfaces. The Bullseye System, along with the related Matryx interference screws, provides customers with an innovative complete system solution for performing anatomic knee reconstructions, an area of medical need.

CONMED Corp. reported unaudited consolidated earnings result for the third quarter and nine months ended September 30, 2009. For the quarter, the company reported sales were $175.5 million compared to $179.4 million in the same quarter of 2008. GAAP diluted earnings per share were $0.04 compared to $0.33 in the third quarter of 2008. Non-GAAP diluted earnings per share equaled $0.28 compared to non-GAAP diluted earnings per share of $0.37 in the 2008 third quarter. Income before income taxes was $1,942,000, income from operations was $5,002,000 and net income was $1,288,000 as compared to income before income taxes was $13,856,000, income from operations was $17,543,000 and net income was $9,735,000 for the same period last year. For nine months, the company reported sales were $504.1 million compared to $562.9 million in the first nine months of 2008. GAAP diluted earnings per share were $0.25 for year-to-date September 2009 compared to $1.09 in the same period of 2008. Non-GAAP diluted earnings per share were $0.63 for the 2009 nine-month period compared to $1.20 in 2008. Income before income taxes was $10,093,000, income from operations was $17,383,000 and net income was $7,182,000 as compared to income before income taxes was $49,511,000, income from operations was $61,235,000 and net income was $31,672,000 for the same period last year. Net cash provided by operating activities was $25,779,000 as compared to $59,686,000 for the same period last year. Purchases of property, plant, and equipment was $17,090,000 and payments related to business acquisitions was $262,000 as compared to purchases of property, plant, and equipment was $25,707,000 and payments related to business acquisitions was $22,033,000 for the same period last year. The company provided earnings guidance for the fourth quarter 2009 and 2010. For the quarter, the company expects sales should approximate $178 to $183 million and that non-GAAP earnings per share should approximate $0.30 to $0.35. For the full year of 2010, the company expects sales to be $715 to $725 million with non-GAAP diluted earnings per share estimated to be $1.20 to $1.30.